Roche and Sanofi Seek Ways to Sidestep Potential Trump Tariffs

Two of Europe’s biggest drugmakers said they’re looking at ways to protect themselves from US President Donald Trump’s potential tariffs.

Switzerland’s Roche Holding AG is moving production for some medicines as well as building inventory in the US and China. And Sanofi is considering more manufacturing investments in the US, where it makes almost half of its sales, a day after France softened its approach to the trade clash with Trump.

Read More: France Strikes Conciliatory Tone to Defuse Trump Trade Tensions

“We are considering additional measures obviously, potentially including investments in the US,” Sanofi’s chief financial officer, ...